More on DMAC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

DiaMedica Therapeutics Inc. (NQ:DMAC)
Delayed: 6.62 +0.15 (2.32%)
Prev. Close $6.47  
Open$6.57 
52 Wk High$ 
52 Wk Low$ 
Day High$6.88 
Day Low$6.57 
P/E N/A  
EPS$ 
Volume14,104 


Aug 12, 2026 04:24 PM Form 4 DiaMedica Therapeutics For: Aug 10 Filed by: Pauls Dietrich John
Aug 11, 2026 08:46 AM Form S-8 DiaMedica Therapeutics
Aug 10, 2026 05:36 PM DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q2 EPS
Aug 10, 2026 04:38 PM Form 10-Q DiaMedica Therapeutics For: Jun 30
Aug 10, 2026 04:36 PM Form 8-K DiaMedica Therapeutics For: Aug 10
Aug 10, 2026 04:30 PM DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Aug 4, 2026 04:30 PM DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026
Jul 17, 2026 04:30 PM DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 23, 2026 08:30 AM DiaMedica doses first patients in Phase 2 fetal growth restriction trial
Jun 23, 2026 08:30 AM DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
View All Articles

Entities mentioned with DMAC

View All Entities